An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical prostatectomy in an early analysis of a first-ever randomized trial. After 6 months ...
Sonablate, a medical technology company focused on non-invasive prostate cancer treatment using high-intensity focused ultrasound (HIFU) , today announced the appointment of Brad Saar, former ...
Non-inferior salvage treatment–free survival at 30 months favored HIFU (90%) versus salvage radical prostatectomy (86%), ...
Learn how to take care of your prostate in your 30s, 40s and beyond, including symptoms to watch for and ways to reduce your ...
Sonire Therapeutics announced today that it initiated its first U.S. clinical trial, SUNRISE-II, evaluating its pancreatic ...
The best time to start keeping your prostate healthy is now. Discover which issues hit younger and older and how to prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results